Table 3. Results of the systematic review and the German Health Interview and Examination Survey for Adults (DEGS1).
| Study first author (reference number) | Outcome: vaccination status | Outcome: immune status | Results*3 | ||||||||||
| Exposed | Not exposed | Exposed | Not exposed | ||||||||||
| N | Positive (%) | [95% CI] | N | Positive (%) | [95% CI] | N | Positive (%) | [95% CI] | N | Positive (%) | [95% CI] | ||
| Varicella zoster | |||||||||||||
| Reignier 2005 (16) | 241 | 99.6 | [96.0; 100] | – | |||||||||
| De Villemeur 2011 (15) | 395 | 100 | – | 382 | 99.7 | – | PR: 1.00*3 | ||||||
| Van Rijckevorsel 2012 (17) | 242 | 100 | [98.7; 100] | 298 | 93.6 | [90.2; 96.2] | PR: 1.07 [1.04; 1.10]*3 | ||||||
| Rubella | |||||||||||||
| Gyorkos 2005 (18) | 476 | 89.8 | – | ||||||||||
| De Villemeur 2011*1 (15) | 395 | 30.2 | – | 382 | 34.5 | – | 395 | 98.7 | – | 382 | 98.2 | – | Vaccination status: PR: 0.87 [0.71; 1.07]*3 Immune status: PR: 1.01 [0.99; 1.02]*3 |
| DEGS1 2015*2 | 100 | 42.9 | [31.8; 54.8] | 2719 | 43.7 | [41.3; 46.0] | 109 | 97.8 | [92.0; 99.4] | 2987 | 96.4 | [95.3; 97.2] | Vaccination status: PR: 0.98 [0.75; 1.29] Immune status: PR: 1.02 [0.98; 1.05] |
| Hepatitis A | |||||||||||||
| Muecke 2004 (19) | 492 | 35.6 | |||||||||||
| DEGS1 2015*2 | 116 | 42.7 | [32.4; 53.7] | 3292 | 29.2 | [27.0; 31.5] | 115 | 49.4 | [37.7; 61.2] | 3099 | 44.6 | [42.1; 47.0] | Vaccination status: PR: 1.46 [1.12; 1.90](*) Immune status: PR: 1.11 [0.87; 1.42] |
| Pertussis (vaccinated in preceding 10 years) | |||||||||||||
| DEGS1 2015*2 | 118 | 22.5 | [14.6; 33.0] | 3169 | 14.3 | [12.6; 16.2] | Vaccination status: PR: 1.57 [1.05; 2.36](*) | ||||||
| Rebmann 2018*1 (20) | 96 | 45.8 | – | ||||||||||
| Measles | |||||||||||||
| DEGS1 2015*2 | 98 | 47.5 | [36.8; 58.5] | 2693 | 39.3 | [36.6; 42.0] | 108 | 91.3 | [82.3; 96.0] | 2988 | 91.7 | [30.0; 93.1] | Vaccination status: PR: 1.21 [0.95; 1.54] Immune status: PR: 1.00 [0.93; 1.07] |
| Mumps | |||||||||||||
| DEGS1 2015*2 | 97 | 34.2 | [24.8; 45.1] | 2673 | 30.6 | [28.3; 33.1] | 108 | 90.0 | [81.4; 94.9] | 2962 | 86.2 | [84.2; 87.9] | Vaccination status: PR: 1.12 [0.82; 1.53] Immune status: PR: 1.04 [0.97; 1.13] |
(*) Significant difference between groups < 0.05
*1Vaccination status determined on basis of self-reported data; *2 vaccination status determined on basis of vaccination passport (70.2 %) and self-reported data (29.8 %); *3 authors‘ own calculation
CI, Confidence interval; PR, prevalence ratio